Orchid Pharma Limited (ORCHPHARMA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Orchid Pharma Limited (ORCHPHARMA) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs115.10 Million ≈ $1.24 Million USD) by net assets (Rs12.74 Billion ≈ $137.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Orchid Pharma Limited for the company's overall valuation and market capitalisation.
Orchid Pharma Limited - Cash Flow Conversion Efficiency Trend (2004–2026)
This chart illustrates how Orchid Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Orchid Pharma Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Orchid Pharma Limited ranked by their cash flow conversion efficiency. Explore Orchid Pharma Limited cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nextdoor Holdings Inc
NYSE:KIND
|
0.007x |
|
Mediterranean Towers Ltd
TA:MDTR
|
0.015x |
|
Puradelta Lestari PT
JK:DMAS
|
-0.022x |
|
Elior SCA
PA:ELIOR
|
0.089x |
|
Beyond, Inc.
NASDAQ:BYON
|
0.121x |
|
Mega-info Media Co.Ltd.
SHE:301102
|
N/A |
|
Kforce Inc.
NASDAQ:KFRC
|
0.177x |
|
Alltop Technology Co Ltd
TWO:3526
|
0.067x |
Annual Cash Flow Conversion Efficiency for Orchid Pharma Limited (2004–2026)
The table below shows the annual cash flow conversion efficiency of Orchid Pharma Limited from 2004 to 2026. View Orchid Pharma Limited stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs12.88 Billion ≈ $139.27 Million |
Rs1.10 Billion ≈ $11.88 Million |
0.085x | +462.76% |
| 2025-03-31 | Rs12.67 Billion ≈ $137.05 Million |
Rs192.15 Million ≈ $2.08 Million |
0.015x | -85.93% |
| 2024-03-31 | Rs11.69 Billion ≈ $126.47 Million |
Rs1.26 Billion ≈ $13.63 Million |
0.108x | +304.58% |
| 2023-03-31 | Rs6.89 Billion ≈ $74.47 Million |
Rs183.38 Million ≈ $1.98 Million |
0.027x | -81.36% |
| 2022-03-31 | Rs6.47 Billion ≈ $70.01 Million |
Rs924.75 Million ≈ $10.00 Million |
0.143x | +295.42% |
| 2021-03-31 | Rs6.53 Billion ≈ $70.61 Million |
Rs235.86 Million ≈ $2.55 Million |
0.036x | -65.76% |
| 2020-03-31 | Rs7.66 Billion ≈ $82.84 Million |
Rs808.03 Million ≈ $8.74 Million |
0.105x | +717.65% |
| 2019-03-31 | Rs-7.04 Billion ≈ $-76.14 Million |
Rs120.24 Million ≈ $1.30 Million |
-0.017x | -47.30% |
| 2018-03-31 | Rs-7.92 Billion ≈ $-85.63 Million |
Rs91.81 Million ≈ $992.84K |
-0.012x | +98.65% |
| 2017-03-31 | Rs-4.67 Billion ≈ $-50.48 Million |
Rs4.01 Billion ≈ $43.36 Million |
-0.859x | -119.85% |
| 2016-03-31 | Rs490.45 Million ≈ $5.30 Million |
Rs2.12 Billion ≈ $22.95 Million |
4.327x | +679.20% |
| 2015-03-31 | Rs3.29 Billion ≈ $35.62 Million |
Rs-2.46 Billion ≈ $-26.61 Million |
-0.747x | -353.59% |
| 2013-03-31 | Rs3.81 Billion ≈ $41.16 Million |
Rs1.12 Billion ≈ $12.12 Million |
0.295x | -52.70% |
| 2012-03-31 | Rs11.83 Billion ≈ $127.98 Million |
Rs7.37 Billion ≈ $79.71 Million |
0.623x | +100.87% |
| 2011-03-31 | Rs10.71 Billion ≈ $115.84 Million |
Rs3.32 Billion ≈ $35.92 Million |
0.310x | +947.20% |
| 2010-03-31 | Rs9.38 Billion ≈ $101.40 Million |
Rs-343.17 Million ≈ $-3.71 Million |
-0.037x | -150.53% |
| 2009-03-31 | Rs6.34 Billion ≈ $68.54 Million |
Rs459.01 Million ≈ $4.96 Million |
0.072x | -77.10% |
| 2008-03-31 | Rs6.65 Billion ≈ $71.92 Million |
Rs2.10 Billion ≈ $22.74 Million |
0.316x | +63.88% |
| 2007-03-31 | Rs4.85 Billion ≈ $52.46 Million |
Rs936.11 Million ≈ $10.12 Million |
0.193x | +1627.98% |
| 2006-03-31 | Rs7.76 Billion ≈ $83.88 Million |
Rs-97.95 Million ≈ $-1.06 Million |
-0.013x | -106.68% |
| 2005-03-31 | Rs4.61 Billion ≈ $49.83 Million |
Rs870.92 Million ≈ $9.42 Million |
0.189x | +667.99% |
| 2004-03-31 | Rs4.10 Billion ≈ $44.38 Million |
Rs-136.54 Million ≈ $-1.48 Million |
-0.033x | -- |
About Orchid Pharma Limited
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, m… Read more